Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendationsAnnals of oncology, 2020-02, Vol.31 (2), p.171-190 [Peer Reviewed Journal]2019 European Society for Medical Oncology ;Copyright © 2019 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2019.10.023 ;PMID: 31959335Full text available |
|
2 |
Material Type: Article
|
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early MonitoringMolecular pharmacology, 2019-08, Vol.96 (2), p.219-232 [Peer Reviewed Journal]Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics. ;ISSN: 0026-895X ;EISSN: 1521-0111 ;DOI: 10.1124/mol.119.115725 ;PMID: 31164387Full text available |
|
3 |
Material Type: Article
|
Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and OpportunitiesJournal of the American College of Cardiology, 2014-09, Vol.64 (9), p.938-945 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2014.06.1167 ;PMID: 25169180 ;CODEN: JACCDIFull text available |
|
4 |
Material Type: Article
|
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJournal of pharmacy and pharmacology, 2013-02, Vol.65 (2), p.157-170 [Peer Reviewed Journal]2012 The Authors. JPP © 2012 Royal Pharmaceutical Society ;2012 The Authors. JPP © 2012 Royal Pharmaceutical Society. ;Copyright © 2012 Royal Pharmaceutical Society ;ISSN: 0022-3573 ;EISSN: 2042-7158 ;DOI: 10.1111/j.2042-7158.2012.01567.x ;PMID: 23278683 ;CODEN: JPPMABFull text available |
|
5 |
Material Type: Article
|
Hypertension and incident cardiovascular events following ibrutinib initiationBlood, 2019-11, Vol.134 (22), p.1919-1928 [Peer Reviewed Journal]2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000840 ;PMID: 31582362Full text available |
|
6 |
Material Type: Article
|
Secondary organic aerosol association with cardiorespiratory disease mortality in the United StatesNature communications, 2021-12, Vol.12 (1), p.7215-8, Article 7215 [Peer Reviewed Journal]2021. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27484-1 ;PMID: 34916495Full text available |
|
7 |
Material Type: Article
|
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialThe Lancet (British edition), 2017-03, Vol.389 (10075), p.1195-1205 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 25, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32616-2 ;PMID: 28215665Full text available |
|
8 |
Material Type: Article
|
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice GuidelinesAnnals of oncology, 2012-10, Vol.23 Suppl 7, p.vii155-vii166 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mds293 ;PMID: 22997448Full text available |
|
9 |
Material Type: Article
|
Cardioprotective interventions for cancer patients receiving anthracyclinesCochrane database of systematic reviews, 2008-01 (2), p.CD003917 [Peer Reviewed Journal]EISSN: 1469-493X ;DOI: 10.1002/14651858.CD003917.pub3 ;PMID: 18425895Full text available |
|
10 |
Material Type: Article
|
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-OncologyMayo Clinic proceedings, 2014-09, Vol.89 (9), p.1287-1306 [Peer Reviewed Journal]Mayo Foundation for Medical Education and Research ;2014 Mayo Foundation for Medical Education and Research ;Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2014 Elsevier, Inc. ;Copyright Mayo Foundation for Medical Education and Research Sep 2014 ;2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. 2014 ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.1016/j.mayocp.2014.05.013 ;PMID: 25192616 ;CODEN: MACPAJFull text available |
|
11 |
Material Type: Article
|
Anthracycline Chemotherapy and CardiotoxicityCardiovascular drugs and therapy, 2017-02, Vol.31 (1), p.63-75 [Peer Reviewed Journal]The Author(s) 2017 ;Cardiovascular Drugs and Therapy is a copyright of Springer, 2017. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-016-6711-0 ;PMID: 28185035 ;CODEN: CDTHETFull text available |
|
12 |
Material Type: Article
|
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and preventionHeart (British Cardiac Society), 2018-06, Vol.104 (12), p.971-977 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2017-312103 ;PMID: 29217634Full text available |
|
13 |
Material Type: Article
|
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-AnalysisJournal of clinical oncology, 2016-09, Vol.34 (26), p.3157-3165 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;Distributed under a Creative Commons Attribution 4.0 International License ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.67.4846 ;PMID: 27458291Full text available |
|
14 |
Material Type: Article
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)European journal of heart failure, 2017, Vol.19 (1), p.9-42 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.654Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the LiteratureDrug safety, 2018-10, Vol.41 (10), p.919-931 [Peer Reviewed Journal]Springer International Publishing AG, part of Springer Nature 2018 ;Copyright Springer Nature B.V. Oct 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0114-5916 ;EISSN: 1179-1942 ;DOI: 10.1007/s40264-018-0689-4 ;PMID: 29858838Full text available |
|
16 |
Material Type: Article
|
Public health: The toxic truth about sugarNature (London), 2012-02, Vol.482 (7383), p.27 [Peer Reviewed Journal]EISSN: 1476-4687 ;DOI: 10.1038/482027a ;PMID: 22297952Full text available |
|
17 |
Material Type: Article
|
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast CancerCirculation (New York, N.Y.), 2019-05, Vol.139 (21), p.2451-2465 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.037357 ;PMID: 30866650Full text available |
|
18 |
Material Type: Article
|
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studiesHaematologica (Roma), 2013-11, Vol.98 (11), p.1753-1761 [Peer Reviewed Journal]Copyright© Ferrata Storti Foundation 2013 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2013.089334 ;PMID: 23935022Full text available |
|
19 |
Material Type: Article
|
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple MyelomaJournal of clinical oncology, 2019-08, Vol.37 (22), p.1946-1955 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00231 ;PMID: 31188726Full text available |
|
20 |
Material Type: Article
|
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean heart journal cardiovascular imaging, 2014-10, Vol.15 (10), p.1063-1093 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com. 2014 ;ISSN: 2047-2404 ;ISSN: 2047-2412 ;EISSN: 2047-2412 ;DOI: 10.1093/ehjci/jeu192 ;PMID: 25239940Full text available |